CLINICAL_TRIALS ClinicalTrials.gov record update

Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05465031
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:44.803418+00:00
Published At: 2025-03-14T00:00:00+00:00
Record Updated At: 2025-03-14
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Breast Cancer", "Neoplasm, Breast", "Breast Diseases", "Antihypertensive Agents", "Sacubitril/Valsartan", "Angiotensin II Type 1 Receptor Blockers", "Angiotensin Receptor Antagonists", "Molecular Mechanisms of Pharmacological Action", "Heart Failure", "Cardiac Toxicity", "Cancer, Therapy-Related", "Cancer Therapy-Related Cardiac Dysfunction", "Cardiotoxicity"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-03-14"
protocolSection.identificationModule.nctId: "NCT05465031"
protocolSection.identificationModule.officialTitle: "Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.